Clinical Trial Update: A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced Breast Cancer [Phase 3]

View source ↗

Summary

Phase III trial of pertuzumab retreatment in patients previously treated with pertuzumab for HER2-positive locally advanced or metastatic breast cancer has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Perjeta (pertuzumab)

Snippet

Sponsor: Japan Breast Cancer Research Group | Conditions: HER2-positive Locally Advanced or Metastatic Breast Cancer | Phase 3 | Status: COMPLETED